Clinical study on the application of intradermal needle to assist in the treatment of chronic stable angina based on the theory of Eight Confluence Point

Institute of Traditional Chinese Medicine, Sichuan Academy of Traditional Chinese Medicine (Sichuan 2nd Hospital of T.C.M)0 sitesTBD

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Not specified
Sponsor: Institute of Traditional Chinese Medicine, Sichuan Academy of Traditional Chinese Medicine (Sichuan 2nd Hospital of T.C.M)
Status: Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

3 years ago

Study Type

Interventional study

Sex

All

Investigators

Sponsor

Institute of Traditional Chinese Medicine, Sichuan Academy of Traditional Chinese Medicine (Sichuan 2nd Hospital of T.C.M)

Eligibility Criteria

Inclusion Criteria

•1\. Patients who meet the diagnostic criteria of chronic stable angina pectoris;
•2\. Patients aged 35\-80 years;
•3\. The patients with more than 2 episodes per week in recent one month;
•4\. Patients with angina pectoris for 3 months or more;
•5\. The subjects signed the informed consent. Note: subjects meeting the above five items should be included in this study.

Exclusion Criteria

•1\. Patients with acute coronary syndrome (including unstable angina pectoris, acute myocardial infarction), atrial fibrillation, severe arrhythmia (severe atrioventricular block, ventricular tachycardia, supraventricular tachycardia affecting hemodynamics, frequent premature beats, especially ventricular premature beats), primary cardiomyopathy and valvular heart disease;
•2\. The patients with hypertension and diabetes who did not reach the standard in clinical treatment;
•3\. Patients with mental disorders, bleeding and allergic constitution;
•4\. Patients who have received acupuncture treatment in the past 3 months;
•5\. Patients who are participating in other clinical trials;
•6\. Pregnant and lactating women;
•7\. Patients with depression score \> 50 or anxiety standard score \> 50\. Note: subjects meeting any of the above criteria should be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting

Phase 2

Facial Pigmentation Treatment by Injection Tranexamic acid intradermally in skiHealth Condition 1: L811- Chloasma

CTRI/2022/02/040450Dr Meghna Khatri

Not yet recruiting

Not Applicable

Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childreHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

CTRI/2019/07/020070Himachal Pradesh University

Not yet recruiting

Phase 1

Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopeciaHair loss.Nonscarring hair loss, unspecifiedL65.9

IRCT20200127046282N34Tehran University of Medical Sciences10

Not yet recruiting

Phase 1

Investigating the safety and efficacy of injection of fat tissue cells in patients with sclerodermascleroderma.Systemic sclerosis [scleroderma]

IRCT20200127046282N35Tehran University of Medical Sciences18

Recruiting

Not Applicable

A study to compare efficacy of intradermal Tranexamic acid injections versus topical Tranexamic acid gel versus topical triple combination (Hydroquinone 2 %, Tretinion 0.025%, Flucinolone acetonide 0.01%) cream in patients suffering from melasma

CTRI/2017/07/009158MGM Medical COllege and Hospital180